These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25620160)

  • 1. Comment to Santos et al., "hyper-IgD and periodic fever syndrome: a new MVK mutation (p.R277G) associated with a severe phenotype".
    Santos Rde L; Crovella S; Celsi F
    Gene; 2015 Mar; 559(1):99-101. PubMed ID: 25620160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyper-IgD and periodic fever syndrome: a new MVK mutation (p.R277G) associated with a severe phenotype.
    Santos JA; Aróstegui JI; Brito MJ; Neves C; Conde M
    Gene; 2014 Jun; 542(2):217-20. PubMed ID: 24656624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome.
    Cuisset L; Drenth JP; Simon A; Vincent MF; van der Velde Visser S; van der Meer JW; Grateau G; Delpech M;
    Eur J Hum Genet; 2001 Apr; 9(4):260-6. PubMed ID: 11313769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group.
    Drenth JP; Cuisset L; Grateau G; Vasseur C; van de Velde-Visser SD; de Jong JG; Beckmann JS; van der Meer JW; Delpech M
    Nat Genet; 1999 Jun; 22(2):178-81. PubMed ID: 10369262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MVK gene abnormality and new approach to treatment of hyper IgD syndrome and periodic fever syndrome].
    Naruto T
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Apr; 30(2):86-9. PubMed ID: 17473510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier frequency of the V377I (1129G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands.
    Houten SM; van Woerden CS; Wijburg FA; Wanders RJ; Waterham HR
    Eur J Hum Genet; 2003 Feb; 11(2):196-200. PubMed ID: 12634869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome.
    Ammouri W; Cuisset L; Rouaghe S; Rolland MO; Delpech M; Grateau G; Ravet N
    Rheumatology (Oxford); 2007 Oct; 46(10):1597-600. PubMed ID: 17804452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa.
    Stojanov S; Lohse P; Lohse P; Hoffmann F; Renner ED; Zellerer S; Kéry A; Shin YS; Haas D; Hoffmann GF; Belohradsky BH
    Arthritis Rheum; 2004 Jun; 50(6):1951-8. PubMed ID: 15188372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome.
    Houten SM; Kuis W; Duran M; de Koning TJ; van Royen-Kerkhof A; Romeijn GJ; Frenkel J; Dorland L; de Barse MM; Huijbers WA; Rijkers GT; Waterham HR; Wanders RJ; Poll-The BT
    Nat Genet; 1999 Jun; 22(2):175-7. PubMed ID: 10369261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and molecular variability in childhood periodic fever with hyperimmunoglobulinaemia D.
    Frenkel J; Houten SM; Waterham HR; Wanders RJ; Rijkers GT; Duran M; Kuijpers TW; van Luijk W; Poll-The BT; Kuis W
    Rheumatology (Oxford); 2001 May; 40(5):579-84. PubMed ID: 11371670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mevalonate kinase deficiency in 2016].
    Galeotti C; Georgin-Lavialle S; Sarrabay G; Touitou I; Koné-Paut I
    Rev Med Interne; 2018 Apr; 39(4):265-270. PubMed ID: 27659743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome.
    Houten SM; Koster J; Romeijn GJ; Frenkel J; Di Rocco M; Caruso U; Landrieu P; Kelley RI; Kuis W; Poll-The BT; Gibson KM; Wanders RJ; Waterham HR
    Eur J Hum Genet; 2001 Apr; 9(4):253-9. PubMed ID: 11313768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyper-igd and periodic fever syndrome: its application as a diagnostic tool.
    Simon A; Cuisset L; Vincent MF; van Der Velde-Visser SD; Delpech M; van Der Meer JW; Drenth JP
    Ann Intern Med; 2001 Sep; 135(5):338-43. PubMed ID: 11529697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico Prediction of the Effects of Mutations in the Human Mevalonate Kinase Gene: Towards a Predictive Framework for Mevalonate Kinase Deficiency.
    Browne C; Timson DJ
    Ann Hum Genet; 2015 Nov; 79(6):451-9. PubMed ID: 26420133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possibly new autoinflammatory disease due to compound heterozygous phosphomevalonate kinase gene mutation.
    Yıldız Ç; Gezgin Yıldırım D; Inci A; Tümer L; Cengiz Ergin FB; Sunar Yayla ENS; Esmeray Şenol P; Karaçayır N; Eğritaş Gürkan Ö; Okur I; Ezgü FS; Bakkaloğlu SA
    Joint Bone Spine; 2023 Jan; 90(1):105490. PubMed ID: 36410683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome.
    Houten SM; Frenkel J; Rijkers GT; Wanders RJ; Kuis W; Waterham HR
    Hum Mol Genet; 2002 Dec; 11(25):3115-24. PubMed ID: 12444096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of the gene for hyper-IgD syndrome: a model of modern genetics].
    Drenth JP; Waterham HR; Kuis W; Houten SM; Frenkel J; Wanders RJ; Poll-The BT; van der Meer JW
    Ned Tijdschr Geneeskd; 2000 Apr; 144(17):782-5. PubMed ID: 10800545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel missense mutation in MVK associated with MK deficiency and dyserythropoietic anemia.
    Samkari A; Borzutzky A; Fermo E; Treaba DO; Dedeoglu F; Altura RA
    Pediatrics; 2010 Apr; 125(4):e964-8. PubMed ID: 20194276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of costimulatory molecules in splenocytes of the mevalonate kinase-deficient mouse model of human hyper-IgD syndrome (HIDS).
    Hager EJ; Piganelli JD; Tse HM; Gibson KM
    J Inherit Metab Dis; 2012 Jan; 35(1):159-68. PubMed ID: 21607759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mevalonate kinase deficiency: Evidence for a phenotypic continuum.
    Simon A; Kremer HP; Wevers RA; Scheffer H; De Jong JG; Van Der Meer JW; Drenth JP
    Neurology; 2004 Mar; 62(6):994-7. PubMed ID: 15037710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.